The incretin approach for diabetes treatment: modulation of islet hormone release by GLP-1 agonism
The incretin approach for diabetes treatment: modulation of islet hormone release by GLP-1 agonism
About this item
Full title
Author / Creator
Publisher
United States: American Diabetes Association
Journal title
Language
English
Formats
Publication information
Publisher
United States: American Diabetes Association
Subjects
More information
Scope and Contents
Contents
Glucagon-like peptide (GLP)-1 is a gut hormone that stimulates insulin secretion, gene expression, and beta-cell growth. Together with the related hormone glucose-dependent insulinotropic polypeptide (GIP), it is responsible for the incretin effect, the augmentation of insulin secretion after oral as opposed to intravenous administration of glucose...
Alternative Titles
Full title
The incretin approach for diabetes treatment: modulation of islet hormone release by GLP-1 agonism
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_67096499
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67096499
Other Identifiers
ISSN
0012-1797
E-ISSN
1939-327X
DOI
10.2337/diabetes.53.suppl_3.S197
